Home/ Stocks/ BRTX

BioRestorative Therapies, Inc. Common Stock (NV)

BRTX XNAS

$0.29 -0.03 (-9.82%) ▼ 15-min delayed

Open

$0.30

High

$0.31

Low

$0.29

Volume

2.49M

Market Cap

$7.06M

About BioRestorative Therapies, Inc. Common Stock (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Sector: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC Employees: 11 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$11.8K	$-3,038,277	$-0.33
Q2 2025	$303.3K	$-2,656,263	$-0.30
Q1 2025	$25.0K	$-5,339,799	$-0.64
FY 2024	$401.0K	$-8,979,381	$-1.16

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

TickerDaily Coverage

Why Is BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Stock Up 32.0% Today?

Penny Stocks Marcus Rivera · Feb 24, 2026

BioRestorative Therapies (BRTX) stock ripped 32.0% higher to $0.2588 on massive volume after...

View All Coverage →

Get BRTX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on BioRestorative Therapies, Inc. Common Stock (NV).

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.